PIOGLITAZONE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where PIOGLITAZONE was used for Psoriasis.
Most Reported Side Effects for PIOGLITAZONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Bladder cancer | 7,295 | 62.0% | 1,522 | 103 |
| Death | 976 | 8.3% | 976 | 24 |
| Bladder transitional cell carcinoma | 398 | 3.4% | 55 | 16 |
| Dyspnoea | 249 | 2.1% | 18 | 139 |
| Drug ineffective | 230 | 2.0% | 2 | 43 |
| Weight increased | 219 | 1.9% | 5 | 50 |
| Hypoglycaemia | 217 | 1.8% | 1 | 133 |
| Cardiac failure | 195 | 1.7% | 18 | 113 |
| Cardiac failure congestive | 194 | 1.7% | 15 | 121 |
| Drug hypersensitivity | 182 | 1.6% | 0 | 8 |
| Oedema peripheral | 166 | 1.4% | 0 | 82 |
| Haematuria | 163 | 1.4% | 24 | 25 |
| Bladder cancer recurrent | 130 | 1.1% | 53 | 4 |
| Blood glucose increased | 128 | 1.1% | 0 | 17 |
| Oedema | 126 | 1.1% | 0 | 45 |
Other Indications for PIOGLITAZONE
Type 2 diabetes mellitus (8,418)
Product used for unknown indication (1,487)
Diabetes mellitus (914)
Metastatic malignant melanoma (32)
Acute myeloid leukaemia (29)
Cardiovascular event prophylaxis (25)
Hodgkin's disease (21)
Blood glucose abnormal (20)
Hyperglycaemia (17)
Blood glucose increased (16)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)